Scott Michael Habig - 20 Feb 2024 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Chief Commercial Officer
Signature
/s/ Scott Habig
Issuer symbol
AUPH
Transactions as of
20 Feb 2024
Net transactions value
-$86,951
Form type
4
Filing time
22 Feb 2024, 16:33:06 UTC
Previous filing
06 Mar 2023
Next filing
07 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Award $0 +195,512 +63% $0.000000 508,231 20 Feb 2024 Direct F1
transaction AUPH Common Stock Sale $86,951 -15,867 -3.1% $5.48 492,364 20 Feb 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
F2 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant.